Valar Atomics and early backer Day One Ventures clash in court over Series B pro-rata rights
What's happening? Nuclear reactor startup Valar Atomics has filed a lawsuit for declaratory relief in the Delaware courts against one of its earliest backers, Day One Ventures, over investor rights in its $1B Series B. Founder and CEO Isaiah TaylorDealroom has a profile for this one. Try Dealroom → disclosed the suit on 9 October 2026 in an X Article. Hours later, Day One general partner Masha BucherDealroom has a profile for this one. Try Dealroom → published the firm's side, and the two accounts differ sharply.
Valar Atomics' Ward 250 reactor units. Image: Valar Atomics
Valar's account: Taylor says Day One put $1M into the seed round and $15M into the Series A, holding under 5% fully diluted but with "Major Investor" status and the pro-rata rights that come with it. After Sequoia pre-empted the Series B, Valar wanted one large existing investor to reinvest strategically, so it asked the other Major Investors to hold their allocations at zero, to avoid triggering a "spring back" clause that would restore everyone's pro-rata rights. Taylor says all agreed except Day One. The day before closing, Major Investors holding a majority of Valar's stock amended the Investor Rights Agreement to remove spring-back rights altogether. Taylor says Day One then hired Quinn EmanuelDealroom has a profile for this one. Try Dealroom → and sent months of demand letters, and that Valar is asking the court to settle the matter and will abide by its ruling.
Day One's account: Bucher says Day One backed Valar repeatedly when it was struggling: it invested in the 2024 seed round, funded a seed extension after what she calls management miscalculations of capital needs, and offered the first term sheet and co-led the Series A after Valar had spent weeks on the market without success. It also waived its pro-rata in the Series A extension at Taylor's request. In return, she says, Valar agreed that Day One's rights to join future rounds could not be removed without its consent. She says four of the six Major Investors took part in the Series B without waiving, that Day One offered to give up most of its Series B pro-rata, and that Valar instead demanded it give up its rights for all future rounds. She also says Day One later learned of a significant secondary share sale by Taylor from which it was excluded, that Valar has refused to hand over documents requested under its information rights, and that Day One has neither taken nor threatened legal action.
Where they disagree: The key factual conflict is whether Day One was the only Major Investor asked to stay out of the Series B, or one of a minority held back while others participated. The court will also have to decide whether a majority of investors could validly strip pro-rata rights that Day One says required its own consent. The secondary sale claim is so far Day One's alone, and Valar has not responded to it publicly.
Why it matters: Public fights between founders and early investors are rare. The case comes after Valar reached criticality on 18 June 2026 and raised at a $6B valuation, and it puts the durability of early-stage pro-rata protections in front of a court just as hot companies are squeezing allocations for new strategic investors.
Read more: Isaiah Taylor on X · Masha Bucher on X · The Information
